Relapse Prevention Study in Patients With Schizophrenia
Public ClinicalTrials.gov record NCT01291511. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate Prevention of Relapse in Patients With Schizophrenia Receiving Either Flexible Dose Iloperidone or Placebo in Long-term Use (up to 26 Weeks) Followed by up to 52 Weeks of Open-label Extension
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether Iloperidone is effective in the prevention of relapse in patients with schizophrenia
Study identification
- NCT ID
- NCT01291511
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 635 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2011 (Actual)
- Primary completion
- Mar 2014 (Actual)
- Completion
- Mar 2015 (Actual)
- Last update posted
- Jul 17, 2023
2011 – 2015
United States locations
- U.S. sites
- 28
- U.S. states
- 12
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vanda Investigative Site | Anaheim | California | 92604 | — |
| Vanda Investigative Site | Bellflower | California | 92706 | — |
| Vanda Investigative Site | Costa Mesa | California | 92626 | — |
| Vanda Investigative Site | Escondido | California | 92025 | — |
| Vanda Investigative Site | La Habra | California | 90631 | — |
| Vanda Investigative Site | Oceanside | California | 92056 | — |
| Vanda Investigative Site | Orange | California | 92868 | — |
| Vanda Investigative Site | Pico Rivera | California | 90660 | — |
| Vanda Investigative Site | Riverside | California | 92506 | — |
| Vanda Investigative Site | San Diego | California | 92102 | — |
| Vanda Investigative Site | San Diego | California | 92103 | — |
| Vanda Investigative Site | San Diego | California | 92121 | — |
| Vanda Investigative Site | Santa Ana | California | 92705 | — |
| Vanda Investigative Site | Melbourne | Florida | 32901 | — |
| Vanda Investigative Site | Miami | Florida | 33126 | — |
| Vanda Investigative Site | Oakland Park | Florida | 33334 | — |
| Vanda Investigative Site | Atlanta | Georgia | 30308 | — |
| Vanda Investigative Site | Atlanta | Georgia | 30328 | — |
| Vanda Investigative Site | St Louis | Missouri | 63109 | — |
| Vanda Investigative Site | Nashua | New Hampshire | 03060 | — |
| Vanda Investigative Site | Marlton | New Jersey | 08053 | — |
| Vanda Investigative Site | Brooklyn | New York | 11235 | — |
| Vanda Investigative Site | Staten Island | New York | 10312 | — |
| Vanda Investigative Site | Hickory | North Carolina | 28601 | — |
| Vanda Investigative Site | Beachwood | Ohio | 44122 | — |
| Vanda Investigative Site | Philadelphia | Pennsylvania | 19139 | — |
| Vanda Investigative Site | Irving | Texas | 75062 | — |
| Vanda Investigative Site | Salt Lake City | Utah | 84106 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 35 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01291511, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 17, 2023 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01291511 live on ClinicalTrials.gov.